Immune marker expression of irradiated mesothelioma cell lines

Immune marker expression of irradiated mesothelioma cell lines

BackgroundThough immune checkpoint inhibition has recently shown encouraging clinical efficacy in mesothelioma, most patients do not respond. Combining immune checkpoint inhibition with radiotherapy presents an attractive option for improving treatment responses owing to the various immunomodulatory...

Full description

Bibliographic Details
Main Authors: Faith Chang, Synat Keam, Tracy Seymour Hoang, Jenette Creaney, Suki Gill, Anna K. Nowak, Martin Ebert, Alistair M. Cook
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
radiotherapy
immune checkpoint inhibition
MHC
PD-L1
mesothelioma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1020493/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1020493/full

Similar Items